Advanced search
Publication Cover
Biomarkers Volume 26, 2021 - Issue 8
Submit an article Journal homepage
127
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A prospective cohort study on association of first-trimester serum biomarkers and risk of isolated foetal congenital heart defects

Mohammad Nasir Hematiana Department of Perinatology and Fetal Cardiology, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
,
Kamran Hessamib Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0003-1722-3553
ORCID Icon,
Shirin Torabic Maternal-Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Maasoumeh Salehc Maternal-Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Behnaz Nourid Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
&
Mahboubeh Salehe School of Medicine, Fasa University of Medical Sciences, Fars, Iran
Pages 747-751 | Received 09 Aug 2021, Accepted 10 Oct 2021, Published online: 27 Oct 2021

References

  • Abib, L.P.A., Sá, RAMd., and Peixoto-Filho, F.M., 2018. First-trimester Combined Screening Test for Aneuploidies in Brazilian Unselected Pregnancies: Diagnostic Performance of Fetal Medicine Foundation Algorithm. Revista brasileira de ginecologia e obstetricia: revista da federacao brasileira das sociedades de ginecologia e obstetricia, 40 (7), 384–389.
  • Abqari, S., et al., 2016. Profile and risk factors for congenital heart defects: A study in a tertiary care hospital. Annals of pediatric cardiology, 9 (3), 216–221.
  • Alanen, J., et al., 2019. First trimester combined screening biochemistry in detection of congenital heart defects. The journal of Maternal-Fetal & neonatal medicine, 32 (19), 3272–3277.
  • Avgidou, K., et al., 2005. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. American journal of obstetrics and gynecology, 192 (6), 1761–1767.
  • Borelli, M., et al., 2017. Critical congenital heart defects and abnormal levels of routinely collected first‐and second‐trimester biomarkers. American journal of medical genetics part A, 173 (2), 368–374.
  • Cavoretto, P., et al., 2017. Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis. Prenatal diagnosis, 37 (6), 540–555.
  • Cedergren, M.I., and Källén, B.A., 2003. Maternal obesity and infant heart defects. Obesity research, 11 (9), 1065–1071.
  • Fantasia, I., et al., 2018. Fetal major cardiac defects and placental dysfunction at 11–13 weeks' gestation. Ultrasound in obstetrics & gynecology, 51 (2), 194–198.
  • Giorgione, V., et al., 2018. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound. Ultrasound in obstetrics & gynecology: the official journal of the international society of ultrasound in obstetrics and gynecology, 51 (1), 33–42.
  • Giorgione, V., et al., 2020. Adverse perinatal outcome and placental abnormalities in pregnancies with major fetal congenital heart defects: A retrospective case-control study. Prenatal diagnosis, 40 (11), 1390–1397.
  • Hollier, L.M., et al., 2000. Maternal age and malformations in singleton births. Obstetrics and gynecology, 96 (5 Pt 1), 701–706.
  • Inversetti, A., et al., 2020. Prenatal Growth in Fetuses with Isolated Cyanotic and Non-Cyanotic Congenital Heart Defects. Fetal diagnosis and therapy, 47 (Suppl. 5), 411–419.
  • Kemper, A.R., et al., 2011. Strategies for implementing screening for critical congenital heart disease. Pediatrics, 128 (5), e1259–e67.
  • Linask, K.K., Han, M., and Bravo-Valenzuela, N.J., 2014. Changes in vitelline and utero-placental hemodynamics: implications for cardiovascular development. Frontiers in physiology, 5, 390.
  • Llurba, E., et al., 2013. Maternal serum placental growth factor at 11–13 weeks' gestation and fetal cardiac defects. Ultrasound in obstetrics & gynecology, 42 (2), 169–174.
  • Makrydimas, G., Sotiriadis, A., and Ioannidis, J.P., 2003. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. American journal of obstetrics and gynecology, 189 (5), 1330–1335.
  • Miller, A., et al., 2011. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. American journal of medical genetics part A, 155 (9), 2137–2145.
  • Spencer, K., et al., 2003. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG: an international journal of obstetrics and gynaecology, 110 (3), 281–286.
  • Stümpflen, I., et al., 1996. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. The lancet, 348 (9031), 854–857.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.